Brad Allan Weeks, the president of VIVOS Inc, has increased his direct equity position in the company through a series of recent stock acquisitions. According to a filing submitted to the Securities and Exchange Commission, the purchases were executed over a two-day period, reflecting a deliberate accumulation of shares.
On July 9, 2026, Mr. Weeks acquired 48,000 shares of VIVOS Inc common stock at a unit price of $0.08. The following day, July 10, 2026, he purchased an additional 12,000 shares, again at $0.08 per share. These transactions, all executed directly, brought the total value of his recent purchases to $4,800.
Following these acquisitions, Mr. Weeks holds a total of 999,235 shares of VIVOS Inc common stock, identified by the ticker symbol RDGL. This insider buying activity occurs as the stock has experienced a notable 45% surge over the past week. However, concurrent analysis by InvestingPro indicates that the shares may be overvalued at current trading levels, which places RDGL on a list of stocks considered to be trading above intrinsic value.
The company operates within the surgical and medical instruments industry and maintains a market capitalization of $40.4 million. Financial data reveals significant operational challenges, with the company reporting revenue of only $80,000 over the last twelve months. These figures highlight ongoing profitability concerns that contrast with the recent price momentum.
Key Points
- VIVOS Inc President Brad Weeks purchased a total of 60,000 shares at $0.08 per share, bringing his direct ownership to 999,235 shares.
- The stock has surged 45% in the past week, yet analysis suggests the shares may be overvalued relative to fundamentals.
- The company operates in the surgical and medical instruments sector, facing profitability pressures with $80,000 in trailing twelve-month revenue against a $40.4 million market cap.
Risks and Uncertainties
- Valuation Risk: Independent analysis suggests the shares may be overvalued, indicating a potential disconnect between price action and underlying business performance.
- Profitability Risk: The company reported minimal revenue of $80,000 over the last twelve months, raising questions about sustainable earnings and operational scaling.